Food-derived linear vs. rationally designed cyclic peptides as potent TNF-alpha inhibitors: an integrative computational study
Open Access
- 18 November 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioinformatics
- Vol. 5, 1716375
Abstract
Introduction: Tumor necrosis factor-alpha (TNF-alpha) is a central mediator of chronic inflammation and a validated therapeutic target in atherosclerosis and related cardiovascular disorders. Peptide therapeutics offer high specificity and low toxicity; however, few natural sequences have been optimized for durable TNF-alpha inhibition. Methods: A dual in silico strategy was employed to identify potent inhibitors: (i) virtual screening of experimentally validated food-derived bioactive peptides and (ii) rational design of an N-C cyclized and disulfide-bridge peptide based on the TNF-alpha-TNFR1 interface. Molecular docking, 200-ns molecular dynamics simulations, and MM/PBSA free-energy analyses were performed. Results: The selected peptides exhibited strong and persistent interactions with key TNF-alpha residues, particularly Tyr119. The cyclic analogue demonstrated deeper free-energy minima, higher binding affinity, and more stable hydrogen-bond networks than the linear sequence. ADMET profiling revealed superior metabolic stability, reduced plasma clearance, and no predicted cardiotoxicity. Discussion: These results indicate that dietary peptides can serve as templates for TNF-alpha inhibition, and interface-guided cyclization rationally enhances stability, binding affinity, and drug-like properties. This study provides a mechanistic framework for developing food-derived peptides as next-generation TNF-alpha antagonists and supports United Nations SDGs 3 and 9 by promoting innovative, low-toxicity therapeutics for chronic inflammation and cardiovascular diseases.Keywords
This publication has 51 references indexed in Scilit:
- Exploring putative drug properties associated with TNF-alpha inhibition and identification of potential targets in cardiovascular disease using machine learning-assisted QSAR modeling and virtual reverse pharmacology approachMolecular Diversity, 2024
- Legume-derived bioactive peptides: role in cardiovascular disease prevention and controlCurrent Opinion in Food Science, 2024
- A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammationBioorganic & Medicinal Chemistry, 2023
- Geo-Measures: A PyMOL plugin for protein structure ensembles analysisComputational Biology and Chemistry, 2020
- Inhibition of human 3-hydroxy-3-methylglutaryl CoA reductase by peptides leading to cholesterol homeostasis through SREBP2 pathway in HepG2 cellsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2019
- CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small moleculesJournal of Computational Chemistry, 2017
- The potential of food protein‐derived anti‐inflammatory peptides against various chronic inflammatory diseasesJournal of the Science of Food and Agriculture, 2015
- Infliximab-induced thrombocytopenia in a patient with ulcerative colitisInternational Journal of Colorectal Disease, 2015
- Computer-Aided Virtual Screening and Designing of Cell-Penetrating Peptides2015
- Tumor necrosis factor, cytokines, and the hyperlipidemia of infectionTrends in Endocrinology & Metabolism, 1991